Emanual Maverakis

Professor

University of California, Davis

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Emanual Maverakis is a Professor at the University of California, Davis, USA. His research areas include myeloma treatment, melanoma progression, patient experiences in pyoderma gangrenosum, and the application of topical probiotics for atopic dermatitis. Dr. Maverakis also investigates the glycomic profiles associated with psoriasis and psoriatic arthritis, as well as innovative therapies targeting interleukin-5 in dermatological conditions.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

L. Renee Ruhaak

Leiden University Medical Center

NETHERLANDS

View details

Roopesh Singh Gangwar

Assistant professor

University of Virginia

UNITED STATES

View details

Nicole L. Ward

Professor and Vice-Chair Basic Research

Vanderbilt University Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Emanual Maverakis

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Clarithromycin, ixazomib, pomalidomide, dexamethasone for relapsed/refractory myeloma: survival and correlative analysis

Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors

A qualitative exploration of patient experiences in pyoderma gangrenosum

A review of topical probiotic therapy for atopic dermatitis

The Psoriasis Glycome: Differential Expression of Cholesterol Particle Glycans and IgA Glycans Linked to Disease Severity

Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriatic Arthritis

Targeting interleukin‐5 with benralizumab: A novel treatment for drug rash with eosinophilia and systemic symptoms

New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine

Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma

Transcriptome analysis of human dermal fibroblasts following red light phototherapy

Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin

Peristomal ulcers misdiagnosed as pyoderma gangrenosum: a common error

Collaborators (3)

L. Renee Ruhaak

Roopesh Singh Gangwar

Nicole L. Ward

Make your next move.